Pfizer Deal Will Help Propel Aurobindo's Revenues To $2 Billion In Three Years
This article was originally published in The Pink Sheet Daily
Executive Summary
Aurobindo's deal with Pfizer encompasses nearly 100 products, mostly tablets and capsules and a few injectables, to be sold in 70 geographies, including the U.S. and Europe..